97P Efficacy and Safety of the Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in Patients with HER2-positive Early Breast Cancer: Long-term Data from the PHranceSCa Study
ESMO Open(2023)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要